Global Allergic Contact Dermatitis (ACDS) Market Size, Status and Forecast 2022

Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The other form of contact dermatitis is irritant contact dermatitis (ICD). Symptoms of allergic contact dermatitis (ACDs) are similar to that of irritant contact dermatitis, which makes the diagnosis harder. The symptoms of allergic contact dermatitis include presence of the skin lesion or rashes at the exposure site. Depending on the allergen type, it may form blisters, papules, simple red spots, vesicles and rashes. The rash can drain, ooze or crust and also becomes raw, thickened or scaled. Allergic contact dermatitis (ACD) is caused as a result of two stages, first stage sensitize and primes the immune system for allergic responses and the second stage, triggers it.   The diagnosis of allergic contact dermatitis includes physical examination and medical therapy. The precise diagnosis based on the symptoms and by rash appearance is very rare. The intermittent or chronic rashes that are not clarified by historical data and physical examination often requires further testing. A patch test (contact delayed hypersensitivity allergy test) is a normally used to detect the actual cause of allergic contact dermatitis.
The global allergic contact dermatitis (ACDS) market is projected to experience rapid growth with increasing prevalence of the diseases and frequently changing lifestyle. The increased focus for the medical treatment of allergic contact dermatitis with perception of providing a comfortable and healthy life, the global allergic contact dermatitis (ACDS) market is anticipated to increase during the forecast period. The key driver of the global allergic contact dermatitis (ACDS) market is the effectiveness of the treatment by reducing the effect of the symptoms. The Increased government concern and improvement in healthcare sectors are some factors facilitating the growth of allergic contact dermatitis (ACDS) market globally. The scarcity of the qualified specialists, equipped amenities, and other skilled professionals for the treatment of allergic contact dermatitis are few factors responsible for restraining the overall growth of the allergic contact dermatitis (ACDS) market.

Market Analysis and Insights: Global Allergic Contact Dermatitis (ACDS) Market
In 2021, the global Allergic Contact Dermatitis (ACDS) market size will be US$ million and it is expected to reach US$ million by the end of 2027, with a CAGR of % during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allergic Contact Dermatitis (ACDS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allergic Contact Dermatitis (ACDS) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allergic Contact Dermatitis (ACDS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allergic Contact Dermatitis (ACDS) market.

Global Allergic Contact Dermatitis (ACDS) Scope and Market Size
Allergic Contact Dermatitis (ACDS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allergic Contact Dermatitis (ACDS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Glucocorticoids
Topical Steroids
Miscellaneous Topical Agents
Corticosteroid
Anticholinergic Antiemetic
Miscellaneous Anxiolytics, Sedatives and Hypnotics

Segment by Application
Topical Administration
Oral Administration

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sandoz
Akorn
Perrigo Company
Taro Pharmaceuticals
Teva Pharmaceuticals
Glenmark Pharmaceuticals

Frequently Asked Questions